Grouping of molecularly targeted anti-cancer agents based on cost-effectiveness analysis
Tirelli, U.; Berretta, M.; Bearz, A.; Carbone, A.
European Review for Medical and Pharmacological Sciences 15(11): 1355-1356
2011
ISSN/ISBN: 1128-3602 PMID: 22195374 Document Number: 653786
Document emailed within 1 workday
Related Documents
Klener, P.; Klener, P. 2012: Molecularly-targeted and biological anti-cancer therapy Folia Biologica 58(1): 1-6Janjigian, Y.Y.; Shah, M.A. 2011: Molecularly targeted therapies in advanced gastric cancer Minerva Gastroenterologica E Dietologica 57(1): 75-88
Nováková, D.; Rozsíval, P. 2004: Evidence based medicine and cost-effectiveness analysis in ophthalmology Ceska a Slovenska Oftalmologie: Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti 60(5): 335-341
Jitapunkul, S.; Bunnag, S.; Ebrahim, S. 1998: Effectiveness and cost analysis of community-based rehabilitation service in Bangkok Journal of the Medical Association of Thailand 81(8): 572-578
Maleewong, U.; Kulsomboon, V.; Teerawattananon, Y. 2008: The cost-effectiveness analysis of initiating HIV/AIDS treatment with efavirenz-based regimens compared with nevirapine-based regimens in Thailand Journal of the Medical Association of Thailand 91(Suppl 2): S126-S138
Campos, N.G.; Maza, M.; Alfaro, K.; Gage, J.C.; Castle, P.E.; Felix, J.C.; Cremer, M.L.; Kim, J.J. 2015: The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador International Journal of Cancer 137(4): 893-902
Hamers, R.L.; Sawyer, A.W.; Tuohy, M.; Stevens, W.S.; Rinke de Wit, T.F.; Hill, A.M. 2012: Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: a model-based analysis Aids 26(13): 1663-1672
Kivela, J; Haldre, K; Part, K; Ketting, E; Baltussen, R 2014: Impact and cost-effectiveness analysis of the national school-based sexuality education programme in Estonia Sex Education 14(1): 1-13
Prinja, S.; Bahuguna, P.; Rudra, S.; Gupta, I.; Kaur, M.; Mehendale, S.M.; Chatterjee, S.; Panda, S.; Kumar, R. 2011: Cost effectiveness of targeted HIV prevention interventions for female sex workers in India Sexually Transmitted Infections 87(4): 354-361
Pho, M.T.; Swaminathan, S.; Kumarasamy, N.; Losina, E.; Ponnuraja, C.; Uhler, L.M.; Scott, C.A.; Mayer, K.H.; Freedberg, K.A.; Walensky, R.P. 2012: The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis Plos one 7(4): E36001
Malila, N.; Anttila, A.; Elovainio, L.; Hakulinen, T.; Järvinen, H.; Paimela, H.; Pikkarainen, P.; Rautalahti, M.; Hakama, M. 2003: Screening of colorectal cancer in Finland and analysis of its cost-effectiveness Duodecim; Laaketieteellinen Aikakauskirja 119(12): 1115-1123
Fanning, J. 1999: Treatment for early endometrial cancer. Cost-effectiveness analysis Journal of Reproductive Medicine 44(8): 719-723
Ishiguro, M.; Sugihara, K.; Ishikawa, T.; Uetake, H. 2011: Perspective on cost-effectiveness analysis of chemotherapy for colorectal cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 3): 589-593
Saito, Y.; Gemma, A. 2011: Interstitial lung disease associated with chemotherapy and molecularly-targeted drug: diagnosis and management Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(13): 2531-2537
Kwon, J.S.; Lu, K.H. 2008: Cost-effectiveness analysis of endometrial cancer prevention strategies for obese women Obstetrics and Gynecology 112(1): 56-63
Ouattara, E.N.; Ross, E.L.; Yazdanpanah, Y.; Wong, A.Y.; Robine, M.; Losina, E.; Moh, R.; Walensky, R.P.; Danel, C.; Paltiel, A.D.; Eholié, S.P.; Freedberg, K.A.; Anglaret, X. 2014: Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'Ivoire Journal of Acquired Immune Deficiency Syndromes 66(3): 294-302
Kim, J.J.; Sharma, M.; O'Shea, M.; Sweet, S.; Diaz, M.; Sancho-Garnier, Hélène.; Seoud, M. 2013: Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA) Vaccine 31 Suppl. 6: G65-G77
Wessels, F.; Anderson, A.N.; Ebrahim, O. 1998: Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients. a pharmaco-economic study based on a meta-analysis South African Medical Journal 88(3): 251-255
Ghosh, S.; Narla, R.K.; Zheng, Y.; Liu, X.P.; Jun, X.; Mao, C.; Sudbeck, E.A.; Uckun, F.M. 1999: Structure-based design of potent inhibitors of EGF-receptor tyrosine kinase as anti-cancer agents Anti-Cancer Drug Design 14(5): 403-410
Zhang, S.X. 1992: Chinese strategies for hepatitis B virus markers screening in hepatitis B vaccination based on cost-effectiveness analysis Zhonghua Yu Fang Yi Xue Za Zhi 26(3): 154-158